Study backs RSV vaccine safety during pregnancy
July 10, 2024
July 10, 2024
ITHACA, New York, July 10 -- Cornell University issued the following news:
Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. Infants are particularly vulnerable to the virus, which can cause a serious lower respiratory illness.
The study, publis . . .
Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. Infants are particularly vulnerable to the virus, which can cause a serious lower respiratory illness.
The study, publis . . .